Amylyx Pharmaceuticals, Inc. AMLX
29.49
(0.65)
(2.16%)
as of 25 Sep
- Market cap
- $3.8B
- P/E
- 0.0×
Follow AMLX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
11.86 | 17.52 | 13.98 | 13.34 | |
Current Ratio |
12.12 | 17.85 | 14.27 | 13.70 | |
Net Debt/EBITDA |
5.35 | 6.32 | 8.44 | 9.26 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.72 | 0.89 | 0.85 | 0.88 | |
Capex/Depreciation |
0.03 | 7.83 | 0.09 | 0.02 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.28) | (0.33) | (0.30) | (0.33) | |
Capex per Share |
0.00 | (0.04) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.28) | (0.37) | (0.30) | (0.33) | |
Cash per Share |
2.26 | 2.53 | 3.35 | 3.69 | |
Shareholders Equity per Share |
2.15 | 2.47 | 3.23 | 3.56 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.15 | 2.47 | 3.23 | 3.56 | |
Free Cash Flow |
(31.45) | (40.88) | (27.99) | (30.39) | |
Working Capital |
235.19 | 269.06 | 300.98 | 327.59 | |
Capital Expenditures |
(0.03) | (4.00) | (0.09) | (0.02) | |
Net Current Asset Value |
230.94 | 264.58 | 296.29 | 322.64 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
— | — | 0.27 | 0.93 | |
Average Payables |
4.41 | 4.17 | 3.23 | 3.41 | |
Average Assets |
229.58 | 256.64 | 263.14 | 306.73 | |
Average Common Equity |
203.52 | 237.29 | 235.01 | 264.10 |
Columns are period end dates